跳至主要内容
临床试验/NCT02330692
NCT02330692Unknown不适用

Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome

Yonsei University1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,000
试验地点
1
主要终点
the number of patients with MDS to examine new prognostic factors

研究概览

简要总结

Developing a molecular genetic test that can identify prognostic factors which can predict response to treatment, and to contribute to the establishment of future therapeutic strategies base on prognostic factors by undergoing peripheral blood and bone marrow examination of Myelodysplastic Syndrome (MDS) patients at diagnosis and relapse.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • MDS diagnosed by bone marrow aspiration and biopsy at Severance Hospital.
  • Male and Female over 16 years of age. ③ Written consent of the patient to participate in the cohort ④ Deaths during the study period are waiver of consent

排除标准

  • ① Refusal or trouble understanding the written consent

结局指标

主要结局

the number of patients with MDS to examine new prognostic factors

时间窗: 10 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验